Personalised medicine, disruptive innovation and ‘trailblazer’ guidelines: Case study and theorization of an unsuccessful change effort
<p><strong>Policy Points:</strong><br /> - For complex reasons, the promise of “precision medicine” based on molecular pathways remains unrealized for many conditions.<br /> - Clinical practice guidelines (theoretically, at least) can act as “trailblazers” to introduce...
| Hlavní autoři: | , |
|---|---|
| Médium: | Journal article |
| Jazyk: | English |
| Vydáno: |
Wiley
2020
|